L
LTRN
Lantern Pharma Inc
1.970
+0.100+5.35%After Hours: 1.940 -0.030 -1.52%19:55 04/10 EDT
OPEN/PREV CLOSE1.920/1.870
TODAY RANGE1.860-2.010
VOL402.45K
MARKET CAP22.17M
52 WEEK RANGE1.110-5.74
AVG VOL (3M)532.45K
% TURNOVER3.58%
TURNOVER--
P/E (TTM)-1.2541
% RANGE8.02%
EPS(TTM)-1.5709
P/E(FORWARD)-1.2548
P/B3.393
BVPS0.5806
DIVIDEND--
P/S1.195
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP18.05M
SHARES OUTSTANDING11.25M
NEXT EARNINGS05/13-05/18
FREE FLOAT9.16M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·21h ago
Lantern Pharma Showcases withZeta.ai Platform for Rare Cancers
TipRanks·04/02 12:15
Lantern Pharma to host live demonstration of withZeta.ai
Benzinga·03/31 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·03/31 14:43
Why Is Vanguard Total Stock Market ETF (VTI) Rising Today, 3/31/26?
TipRanks·03/31 13:47
Lake Street Reaffirms Their Buy Rating on Lantern Pharma (LTRN)
Benzinga·03/31 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·03/30 23:04
Lantern Pharma Reports 2025 Results and Pipeline Progress
TipRanks·03/30 22:35
Closing Bell Movers: Phreesia down over 20% after guidance cut
TipRanks·03/30 20:22
Lantern Pharma reports Q4 net income ($4.1M) vs ($5.9M) last year
Benzinga·03/30 20:22
Lantern Pharma Q4 EPS $(0.36) Beats $(0.46) Estimate
TipRanks·03/30 20:21
Lantern Pharma says article on CEO leaving ‘false and misleading’
Dow Jones·03/30 20:13
*Lantern Pharma 4Q Loss $4.1M >LTRN